RecallDepth
Class III Terminated

Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031

This recall has been terminated (originally issued November 21, 2018).

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
November 6, 2018
Posted
November 21, 2018
Recall Number
D-0279-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
9,193 bottles
Firm Location
Boca Raton, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 5599.008A, 5599.009A, 5599.010A, Exp. 04/2019; 5599.012A, 5599.013A, Exp. 11/2019; 5599.014A, Exp. 01/2020

Other recent Class III Drug recalls